Amarin Corp Plc (AMRN)

[Whalatane]

North et al Amarin is disclosing

" additional truthful and non misleading information " , which includes the following


*These trials included a total of 170,000 participants in statin trials and demonstrated that, with each 1.0 mmol/L (39 mg/dL) reduction in LDL-C, the proportional annual risk of major vascular events was reduced by 22%."

Now you and JL et al can disagree with this all you like BUT Amarin believes this to be truthful and non misleading .

" Even on sunny days , there will be some that see only clouds "

Kiwi